Literature DB >> 20119649

Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure.

Marc R Bothe1, Ingo Uttner, Markus Otto.   

Abstract

Older adults suffering from Parkinson's disease (PD) frequently present with an additional form of severe neurodegenerative and/or vascular pathology. Findings of differential clinical manifestations of cognitive impairment, depending on presence and nature of such coexisting brain pathology, raise the question for neuropsychological procedures that are capable not only of distinguishing between non-demented PD patients and patients with Parkinson-associated dementia (PDD), but also of detecting other types of cognitive decline, most likely Alzheimer's disease (AD) or vascular dementia (VD), superimposing PD. The aim of this article is to review the literature on neuropsychological processes at risk in developing PDD, to introduce comorbid causes of cognitive decline in the presence of PD, to discuss the scope of the "cortical versus subcortical dementia"-concept in view of its capability of differentiating dementias, and to scrutinize existing diagnostic criteria concerning the toleration of comorbidity. Additionally, we derive an evidence-based neuropsychological diagnostic procedure for assessing PDD under special consideration of these comorbid aspects.

Entities:  

Mesh:

Year:  2010        PMID: 20119649     DOI: 10.1007/s00702-010-0370-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  91 in total

1.  The effects of additional pathology on the cognitive deficit in Alzheimer disease.

Authors:  Z Nagy; M M Esiri; K A Jobst; J H Morris; E M King; B McDonald; C Joachim; S Litchfield; L Barnetson; A D Smith
Journal:  J Neuropathol Exp Neurol       Date:  1997-02       Impact factor: 3.685

2.  Study of verbal working memory in patients with Parkinson's disease.

Authors:  Brigitte Gilbert; Sylvie Belleville; Louis Bherer; Sylvain Chouinard
Journal:  Neuropsychology       Date:  2005-01       Impact factor: 3.295

3.  Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia.

Authors:  S E Starkstein; L Sabe; G Petracca; E Chemerinski; G Kuzis; M Merello; R Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

4.  Reaction time in Parkinson's disease.

Authors:  E V Evarts; H Teräväinen; D B Calne
Journal:  Brain       Date:  1981-03       Impact factor: 13.501

5.  Recall and recognition memory in Parkinson's disease.

Authors:  E K Breen
Journal:  Cortex       Date:  1993-03       Impact factor: 4.027

6.  Cognitive profile of patients with newly diagnosed Parkinson disease.

Authors:  Dino Muslimovic; Bart Post; Johannes D Speelman; Ben Schmand
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

7.  Cognitive impairments in advanced PD without dementia.

Authors:  J Green; W M McDonald; J L Vitek; M Evatt; A Freeman; M Haber; R A E Bakay; S Triche; B Sirockman; M R DeLong
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

8.  The Bayer Activities of Daily Living Scale (B-ADL).

Authors:  I Hindmarch; H Lehfeld; P de Jongh; H Erzigkeit
Journal:  Dement Geriatr Cogn Disord       Date:  1998       Impact factor: 2.959

Review 9.  Restless legs syndrome and PD: a review of the evidence for a possible association.

Authors:  Diego Garcia-Borreguero; Per Odin; Carolina Serrano
Journal:  Neurology       Date:  2003-09-23       Impact factor: 9.910

10.  Validation of the Geriatric Depression Scale--Short Form among inpatients.

Authors:  E L Lesher; J S Berryhill
Journal:  J Clin Psychol       Date:  1994-03
View more
  5 in total

Review 1.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.

Authors:  Irene Litvan; Jennifer G Goldman; Alexander I Tröster; Ben A Schmand; Daniel Weintraub; Ronald C Petersen; Brit Mollenhauer; Charles H Adler; Karen Marder; Caroline H Williams-Gray; Dag Aarsland; Jaime Kulisevsky; Maria C Rodriguez-Oroz; David J Burn; Roger A Barker; Murat Emre
Journal:  Mov Disord       Date:  2012-01-24       Impact factor: 10.338

Review 2.  Parkinson's disease dementia and potential therapeutic strategies.

Authors:  John N Caviness; LihFen Lue; Charles H Adler; Douglas G Walker
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

3.  Differential sialylation of serpin A1 in the early diagnosis of Parkinson's disease dementia.

Authors:  Sarah Jesse; Stefan Lehnert; Olaf Jahn; Lucilla Parnetti; Hilkka Soininen; Sanna-Kaisa Herukka; Petra Steinacker; Saskia Tawfik; Hayrettin Tumani; Christine A F von Arnim; Manuela Neumann; Hans A Kretzschmar; Hasan Kulaksiz; Martin Lenter; Jens Wiltfang; Boris Ferger; Bastian Hengerer; Markus Otto
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

4.  Profile of cognitive impairment in late-stage Parkinson's disease.

Authors:  Catarina Severiano E Sousa; Margherita Fabbri; Catarina Godinho; Rita Moiron Simões; Inês Chendo; Miguel Coelho; Isabel Pavão Martins; Joaquim J Ferreira
Journal:  Brain Behav       Date:  2022-03-07       Impact factor: 3.405

5.  Towards Consensus on Essential Components of Physical Examination in Primary Care-based Memory Clinics.

Authors:  George A Heckman; Bryan B Franco; Linda Lee; Loretta Hillier; Veronique Boscart; Paul Stolee; Lauren Crutchlow; Joel A Dubin; Frank Molnar; Dallas Seitz
Journal:  Can Geriatr J       Date:  2018-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.